| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/22/2003 | US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 05/22/2003 | US20030096302 Detection of preferential particles in sample: obtain sample, expose sample to light, monitor sample response to light |
| 05/22/2003 | US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
| 05/22/2003 | US20030096295 Detection of vision defects; provide nucleotide sequence sample, determine nucleotide sequence of target nucleic acid, evaluate sequence for mutation associated with genetic disorder |
| 05/22/2003 | US20030096292 Method of making high density arrays |
| 05/22/2003 | US20030096291 Multiplex oligonucleotide addition and target amplification |
| 05/22/2003 | US20030096290 Methods for cancer prognosis and diagnosis |
| 05/22/2003 | US20030096289 Oligonucleotide-immobilized substrate for detecting methylation |
| 05/22/2003 | US20030096287 Oligonucleotide for use as diagnostic tool in genetic engineering |
| 05/22/2003 | US20030096286 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 05/22/2003 | US20030096284 Detection of amplified gene sequences in sample; obtain sample nucleotide sequences, incubate with primers, amplify, expose to marker probe, detect signal, presence of signal indicates target sequences |
| 05/22/2003 | US20030096283 Electrochemical detection of single base extension |
| 05/22/2003 | US20030096282 Gtpase-activating protein 1 |
| 05/22/2003 | US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/22/2003 | US20030096278 Determination of nucleotide sequences using overlapping oligonucleotides; obtain genomic nucleotide sequences, incubate with overlapping oligonucleotides, amplify sequences, recover products, determine sequence of product |
| 05/22/2003 | US20030096277 Allele specific PCR for genotyping |
| 05/22/2003 | US20030096276 22325, a human biotin-requiring enzyme family member and uses therefor |
| 05/22/2003 | US20030096275 Kit for the detection of preferential particles in sample |
| 05/22/2003 | US20030096274 Method of screening for drug hypersensitivity reaction |
| 05/22/2003 | US20030096273 Methods for immobilizing molecules to a solid phase and uses thereof |
| 05/22/2003 | US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders |
| 05/22/2003 | US20030096269 Method for detecting genomic destabilization arising during tissue culture of plant cells |
| 05/22/2003 | US20030096268 Apparatus for use in the amplification and sequence determination of polynucleotide |
| 05/22/2003 | US20030096267 Essential bacterial genes and their use |
| 05/22/2003 | US20030096265 The formed probe for use in a microarray analysis to bond covalently to a hydrogel; solid phase synthsis |
| 05/22/2003 | US20030096263 Detection of enzyme inhibitors; obtain sample containing enzyme of interest, incubate with modulator, detect adjustment in enzyme activity, reduction in activity indicates enzyme inhibitor |
| 05/22/2003 | US20030096262 Diagnosing cancer in humans; obtain tissue, extract nucleotide sequences, screen for deletion of preferential sequences, loss of sequences indicates sensitivity to cancer |
| 05/22/2003 | US20030096261 Determining gene expression profile of vascular endothelial cells; obtain cells, incubate with immunological agent, isolate bound cells, extract ribonucleic acid sequences, expose to probe, monitor expression profile |
| 05/22/2003 | US20030096258 Solid phase sequencing of double-stranded nucleic acids |
| 05/22/2003 | US20030096256 Additive to add discrimination means and matter maintaining discrimination information which containing the additive |
| 05/22/2003 | US20030096255 Methods and kits for analysis of chromosomal rearrangements associated with cancer |
| 05/22/2003 | US20030096254 Enhancing resonance ability of oligonuclotide probes for use in hybridization assays; gene expression |
| 05/22/2003 | US20030096253 Single nucleotide amplification and detection by polymerase |
| 05/22/2003 | US20030096252 Hybridization of preferential nucleotide sequence to target nucleic acid; obtain nucleic acid sample, incubate with detection probe, detect signal, presence of signal indicates presence of target nucleic acid |
| 05/22/2003 | US20030096251 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 05/22/2003 | US20030096248 Diagnosis and evaluation of therapy for cardiovascular disorders; obtain tissue sample, extract nucleotide sequences, detect presence of target sequence, evaluate for use as therapy candidate for cardiovascular disorder |
| 05/22/2003 | US20030096247 Human cDNAs and proteins and uses thereof |
| 05/22/2003 | US20030096245 Invasive cleavage of nucleic acids |
| 05/22/2003 | US20030096244 Diagnosis of parasitic infections; obtain sample, extract nucleotide sequences, incubate with primer, amplify sequences, separate products, incubate with probes and detect signal, presence of signal indicates presence of parasite |
| 05/22/2003 | US20030096243 Measurement of gene expression in target cells; provide genetically engineered cells which express labeled nucleotide sequences, scanning the cells to obtain fluorescent signals, determine concentration of nucleotide sequences |
| 05/22/2003 | US20030096242 Oligonucleotide probes for detecting nucleic acids through changes in flourescence resonance energy transfer |
| 05/22/2003 | US20030096241 Method of testing squamous epithelial cells |
| 05/22/2003 | US20030096239 Probes and decoder oligonucleotides |
| 05/22/2003 | US20030096238 Compositions and methods relating to gynecologic cancer specific genes |
| 05/22/2003 | US20030096237 Determination of the ability of patients to respond to a tumor treatment |
| 05/22/2003 | US20030096236 Determining common functional alleles in a population and uses therefore |
| 05/22/2003 | US20030096235 Complexity management of genomic DNA |
| 05/22/2003 | US20030096234 Monitoring preferential gene expression profile; obtain cellsample, incubate with modulator, monitor gene expression profile, compare to control, evaluate gene expression |
| 05/22/2003 | US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/22/2003 | US20030096232 High throughput assay system |
| 05/22/2003 | US20030096231 Determination of haploid genotype of sample; obtain nucleotide sequences, detect polymorphism, classify genotype |
| 05/22/2003 | US20030096229 Manipulating genetic material; obtain cells, disrupt, expose to column, label nucleotide sequences, elute labeled sequences |
| 05/22/2003 | US20030096228 Nucleotide sequences for use as diagnostic tool for detection of bacteria in sample |
| 05/22/2003 | US20030096226 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitope |
| 05/22/2003 | US20030096225 Recovering preferential protein from library; obtain cell, transform with vector, express vector, isolate preferential protein |
| 05/22/2003 | US20030096224 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 05/22/2003 | US20030096222 Detection of preferential hepatitis virus; generate expresson vector containing viral gene, incubate with and transform cells, propagate cells, lyse cells, recover viral particles expressing preferential activities |
| 05/22/2003 | US20030096220 Capillary array-based sample screening |
| 05/22/2003 | US20030096016 Methods of kidney transplantation utilizing developing nephric tissue |
| 05/22/2003 | US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 05/22/2003 | US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152 |
| 05/22/2003 | US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association |
| 05/22/2003 | US20030095960 Three human transferases, polynucleotides that identify and encode them, expression vectors, host cells, antibodies, agonists, and antagonists. |
| 05/22/2003 | US20030095897 Flow-controlled magnetic particle manipulation |
| 05/22/2003 | US20030094384 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes |
| 05/22/2003 | CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 05/22/2003 | CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 05/22/2003 | CA2467347A1 Histamine receptor h3 polynucleotides |
| 05/22/2003 | CA2466890A1 Novel isoamylases and associated methods and products |
| 05/22/2003 | CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 05/22/2003 | CA2466703A1 Method for characterising and/or identifying active mechanisms of antimicrobial test substances |
| 05/22/2003 | CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 05/22/2003 | CA2466420A1 A novel saitohin gene and uses of same |
| 05/22/2003 | CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor |
| 05/22/2003 | CA2466346A1 Single nucleotide polymorphisms in gh-1 |
| 05/22/2003 | CA2466279A1 Agents that modulate immune cell activation and methods of use thereof |
| 05/22/2003 | CA2466264A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof |
| 05/22/2003 | CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 05/22/2003 | CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 05/22/2003 | CA2465588A1 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 05/22/2003 | CA2464942A1 Signal system and elements used therein |
| 05/22/2003 | CA2464383A1 Sequence variants of the human growth hormone gene and methods for detection |
| 05/22/2003 | CA2463639A1 Growth hormone variations in humans and their uses |
| 05/22/2003 | CA2461481A1 Ptp1b inhibitors and ligands |
| 05/22/2003 | CA2460959A1 Enzymes |
| 05/22/2003 | CA2454031A1 Novel chromophores/fluorophores and methods for using the same |
| 05/22/2003 | CA2450109A1 Electronic detection of biological molecules using thin layers |
| 05/21/2003 | WO2004041156A2 Method for determining sensitivity to a bacteriophage |
| 05/21/2003 | EP1312922A1 Stabilized tetrazolium reagent compositions with nitrite and methods for using the same |
| 05/21/2003 | EP1312921A1 Stabilized tetrazolium-phenazine reagent compositions and methods for using the same |
| 05/21/2003 | EP1312685A2 Oligonucleotide array for detecting the methylation state |
| 05/21/2003 | EP1312684A2 Quantitative multiplex PCR with high dynamic range |
| 05/21/2003 | EP1312682A1 Method of amplifying nucleic acid |
| 05/21/2003 | EP1312681A1 Method for identifying therapeutic targets by use of genetic screens in Drosophila melanogaster |
| 05/21/2003 | EP1312674A1 Allosteric ribozymes and uses thereof |
| 05/21/2003 | EP1312673A1 Method of protecting personal information |
| 05/21/2003 | EP1312259A1 Type iii allergic inflammation model animal |
| 05/21/2003 | EP1311858A2 Affinity selected signature peptides for protein identification and quantification |
| 05/21/2003 | EP1311854A2 Microfuidic device and method with trapping of sample in carities having lids that can be opened or closed |
| 05/21/2003 | EP1311852A1 Methods and molecules useful for identifying molecules that bind lfa-1 and for determining receptor occupancy |